HPV+ HNSCC cells were particularly sensitive to roscovitine, because roscovitine treatment selectively induced DNA damage, thus triggering p53-dependent cell death in HPV+, but not in HPV- HNSCC cells. Here, TP53 is linked to head and neck squamous cell carcinoma.